Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhab domyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group
A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study (vol 133, pg 537, 2014)
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients
A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group Study
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee: Response
A phylogeny of Cichlidogyrus spp. (Monogenea, Dactylogyridea) clarifies a host-switch between fish families and reveals an adaptive component to attachment organ morphology of this parasite genus
A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis
A physical model for the flickering variability in cataclysmic variables
A photodissociation region study of NGC 4038
A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin
A phantom for simplified image quality control of dental cone beam computed tomography units
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma
A phase-dependent comparison of the velocity parameters of SiO v=1, J=1-0 and J=2-1 maser emission in long-period variables
A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma
A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis
A physical limitation of the Wigner "distribution" function in molecular transport
A phase I study of ABT-510 plus bevacizumab in advanced solid tumors
A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery
A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy
A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer
A phase 1 study to evaluate effect of food on veliparib pharmacokinetics and relative bioavailability in subjects with solid tumors
A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors
A phase II trial of a transmucosal herbal patch for the treatment of gingivitis
A photoionization model of the spatial distribution of the optical and mid-infrared properties in NGC 595
A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma
A phase II, randomized, double-blind, parallel-group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy
A phase adaptive cache hierarchy for SMT processors
A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer
A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer
A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom
A physically based, accurate compact model of direct tunneling gate current considering quantum mechanical effects in nanoscale metal-oxide-semiconductor field-effect transistors
A phase 1 enzyme replacement study offers promise for severe hypophospahatasia
A physics-based approach to flow control using system identification
A phase-field model of stress effect on grain boundary migration
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors
A physiotherapy perspective of musculoskeletal imaging in sport
A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignancies
A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study
A photometric function for analysis of lunar images in the visual and infrared based on Moon Mineralogy Mapper observations
A phase I dose-finding study based on polychotomous toxicity responses
A physical model of sensorimotor interactions during locomotion
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515
A photometric and spectroscopic study of WW And - an Algol-type, long period binary system with an accretion disc
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
A phenomenological model for circadian and sleep allostatic modulation of plasma cortisol concentration
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer
A physically based methodology to extrapolate performance maps of radial turbines
A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer
A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
A photogrammetric method to evaluate nutritional status without capture in habituated free-ranging Japanese macaques (Macaca fuscata): a pilot study
A photovoltaic panel emulator using a buck-boost DC/DC converter and a low cost micro-controller
A phase II randomized study of Combined Infusional Leucovorin Sodium and 5-FU versus the Leucovorin Calcium followed by 5-FU both in combination with Irinotecan or Oxaliplatin in patients with metastatic colorectal cancer
A pharmacological study of NLP-12 neuropeptide signaling in free-living and parasitic nematodes
A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) study
A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours
A physiology-based inverse dynamic analysis of human gait using sequential convex programming: a comparative study
A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research
A pharmacy medication alert system based on renal function in older patients
A photocleavable affinity tag for the enrichment of alkyne-modified biomolecules
A phase-separable second-generation hoveyda-grubbs catalyst for ring-opening metathesis polymerization (vol 50, pg 3954, 2012)
A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer
A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
A phase I study of the vitamin D-3 analogue ILX23-7553 administered orally to patients with advanced solid tumors
A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury
A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma
A phase II, single-arm study of the anti-alpha 5 beta 1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study
A photonic spectral processor employing two-dimensional WDM channel separation and a phase LCoS modulator
A philosopher looks at string dualities
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
A phase-field simulation of uranium dendrite growth on the cathode in the electrorefining process
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naive patients with advanced melanoma
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS